Publications

April 2025

CJEU revisits Art. 3(a) and 3(c) of the SPC Regulation – Teva BV u.a. vs Merck Sharp & Dohme Corp

Authors:
Dr. Michael Best, Dr. Oliver Ladendorf,
Dr. Jonas Thelemann

Read more …

January 2021

Practical consequences of the new Rules of Procedure of the Boards of Appeal

Authors:
Dr. Evy Corbanie, Dr. Stefan Weist,
Dr. Marc Gerauer

Read more …

October 2020

Patent Infringement in 3D Printing
Technology and Liability of the Managing Director

Author:
Dr. Marc Gerauer

Read more …

June 2020

Divide and conquer!
A proposal for an amended Rule 36 EPC

Author:
Horst Vissel

Read more …

July 2018

Patentverletzung im Hinblick auf den 3D-Druck und Geschäftsführerhaftung

Author:
Dr. Marc Gerauer

Read more …

June 2018

Der nächste Quantensprung in der Molekularbiologie

Author:
Dr. Oliver Ladendorf

Read more …

May 2017

Patentability of products obtained by essentially biological processes in Europe

Authors:
Dr. Oliver Ladendorf, Dr. Evy Corbanie

Read more …

April 2016

What is the relevant date of marketing authorization to determine the term of an SPC?

Authors:
Dr. Oliver Ladendorf, Dr. Alexander Kleefen

Read more …

April 2016

May a part of a fusion protein be considered an "active ingredient"? Yes, says the ECJ in Forsgre

Authors:
Dr. Oliver Ladendorf, Dr. Alexander Kleefen

Read more …

March 2016

Eli Lilly vs. HGS (C-493/12):
The UK High Court clarifies the ECJ's enigmatic decision

Authors:
Dr. Oliver Ladendorf, Dr. Alexander Kleefen

Read more …